Technology

We developed a technology that we called “Preferential Amplification of Pathogenic Sequences (PATHseq®)” that can be used to greatly enrich pathogenic sequences in human clinical samples. This method does not require prior knowledge of the pathogen or assumption of the infection, and therefore, provides a fast and sequence-independent approach to identify human pathogens. This technology was awarded U.S. Patent No. 11,035,000 - Methods and Compositions for Enriching Non-Host Sequences in Host Samples. PATHseq® is a registered trademark of PATHseq® Diagnostics, Inc.